We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

CTI Acquires Mirada Solutions

By HospiMedica staff writers
Posted on 12 Sep 2003
In a move to enhance the company's positron emission tomography (PET) systems, CTI Molecular Imaging, Inc. (Knoxville, TN, USA) has acquired Mirada Solutions Limited (Oxford, UK). Terms were not disclosed.

Mirada, a spinoff from Oxford University, is a developer of fusion software applications for medical imaging workstations. CTI plans to incorporate Mirada's image analysis and fusion software into all its PET scanner workstations, to enhance the analytical and diagnostic capabilities of its PET systems. Mirada has developed several products designed to provide better detection, diagnosis, and disease management through the application of image analysis software to medical images.

"We believe that we have acquired the best-in-class capability that will further distinguish our PET scanners in the marketplace,” said Terry Douglas, chairman and CEO of CTI. "With this acquisition, we not only offer the fastest scan time through our proprietary LSO technology, but we also provide the greatest level of PET image functionality for the clinician.”





Related Links:
CTI
Mirada
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Ultrasonic Dissector
SONICBEAT
New
Half Apron
Demi

Channels

Critical Care

view channel
Image: Researchers have taken a major step toward cuff-free blood pressure monitoring (Photo courtesy of Gwyneth Moe/Boston University)

Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension

Hypertension affects nearly half of all adults in the U.S. and remains the leading cause of cardiovascular disease. Regular and accurate blood pressure monitoring is essential for managing this condition,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more